MFMuneeb A. Faiq

Muneeb A. Faiq

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Muneeb A. Faiq has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Functional genomics of primary congenital glaucoma by pathway analysis and functional characterization of CYP1B1 mutations

    by Muneeb A. Faiq, Himanshu N. Singh, Mashooq Ali, Rima Dada, Kevin C. Chan, Tanuj Dada, Daman Saluja


  • Genetic Fallacy

    by Muneeb A. Faiq

  • Open Access

    Morphological Integration in Human Skull and Its Possible Role in Etiogenesis of Neuropsychiatric Disorders: Deciphering the Link between Evolution, Development and Disease

    by Ashutosh Kumar, Sada N. Pandey, Muneeb A. Faiq, Vikas Pareek, Ravi K. Narayan

    Structure - function interdependence is a universal phenomenon in biological systems. Any alteration in structural features may result in change in functions–leading to natural selection of a particular trait, or dysfunctions thereof. Many such alterations arise during the course of evolution of a species and may meticulously be traced during embryonic development of an organism. Through the theoretical construct of morphological integration, a set of phenotypic traits alter in a coordinated and integrated manner during evolution and embryonic development of an organism yielding efficient environmentally adapted physiological functions pertinent to those structures. Such integration may go awry sometimes, setting the basis for genesis of diseases. Morphological integration in human skull has been established through various methods. The brain-skull co-development is handcuffed through evolution and development, and the very basis of a neuro-psychiatric disorder could be underlying in dysmorphogenesis of the skull, its consequent effect on structures, and thus functions of the pertinent brain components. Here we propose that morphological integration in human skull may be mechanistically implied in etiogenesis of certain neuro-psychiatric disorders and should be borne in mind during clinical diagnosis and therapeutic interventions.

  • Open Access

    Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients

    by Ashutosh Kumar, Muneeb A. Faiq, Vikas Pareek, Khursheed Raza, Ravi K. Narayan, Pranav Prasoon, Pavan Kumar, Maheswari Kulandhasamy, Chiman Kumari, Kamla Kant, et al.

    Introduction: COVID-19 is caused by a new strain of coronavirus called SARS-coronavirus-2 (SARS-CoV-2), which is a positive sense single strand RNA virus. In humans, it binds to angiotensin converting enzyme 2 (ACE2) with the help a structural protein on its surface called the S-spike. Further, cleavage of the viral spike protein (S) by the proteases like transmembrane serine protease 2 (TMPRSS2) or Cathepsin L (CTSL) is essential to effectuate host cell membrane fusion and virus infectivity. COVID-19 poses intriguing issues with imperative relevance to clinicians. The pathogenesis of GI symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 are of particular relevance because they cannot be sufficiently explained from the existing knowledge of the viral diseases. Tissue specific variations of SARS-CoV-2 cell entry related receptors expression in healthy individuals can help in understanding the pathophysiological basis the aforementioned collection of symptoms. Materials and Methods: The data were downloaded from the Human Protein Atlas available at ( https://www.proteinatlas.org/humanproteome/sars-cov-2 ) and the tissue specific expressions (both mRNA and protein) of ACE2 and TMPRSS2 as yielded from the studies with RNA sequencing and immunohistochemistry (IHC) were analyzed as a function of the various components of the digestive tract. A digestive system specific functional enrichment map of ACE2 gene was created using g:profiler ( https://biit.cs.ut.ee/gprofiler/gost ) utility and the data were visualized using Cytoscape software, version 3.7.2 ( https://cytoscape.org/ ). Results: The correlated expression (transcriptomic and proteomic) of ACE2 (to which SARS-CoV-2 binds through the S-spike) was found to be enriched in the lower gastrointestinal tract (GIT) (highest in small intestine, followed by colon and rectum), and was undetectable in the upper GIT components: mouth cavity (tongue, oral mucosa, and salivary glands), esophagus, and stomach. High expression of ACE2 was noted in the glandular cells as well as in the enterocytes in the lining epithelium (including brush border epithelium). Among other digestive system organs, Gall bladder (GB) showed high expression of ACE2 in glandular cells, while any protein expression was undetectable in liver and pancreas. TMPRSS2 was found enhanced in GIT and exocrine glands of pancreas, and co-localized with ACE2 in enterocytes. Conclusions: Based on the findings of this study and supportive evidence from the literature we propose that a SARS-CoV-2 binding with ACE2 mediates dysregulation of the sodium dependent nutrient transporters and hence may be a plausible basis for the digestive symptoms in COVID-19 patients. ACE2 mediated dysregulation of sodium dependent glucose transporter (SGLT1 or SLC5A1) in the intestinal epithelium also links it to the pathogenesis of diabetes mellitus which can be a possible reason for the associated mortality in COVID-19 patients with diabetes. High expression of ACE2 in mucosal cells of the intestine and GB make these organs potential sites for the virus entry and replication. Continued replication of the virus at these ACE2 enriched sites may be a basis for the disease recurrence reported in some, thought to be cured, patients. Graphical


  • Open Access

    COVID-19: A Review on Molecular Basis, Pathogenic Mechanisms, Therapeutic Aspects and Future Projections

    by Muneeb Faiq, Ashutosh Kumar, Himanshu Singh, Vikas Pareek, Rizwana Qadri, Khursheed Raza, Chiman Kumari, Ravi Narayan, Pavan Kumar, Maheswari Kulandhasamy, et al.

    The SARS-CoV-2 is a recently identified positive sense single stranded RNA virus and member of the coronavirus family of viruses. It is thought to be the etiological factor for the ongoing COVID-19 pandemic. This virus is thought to have originated from bats and acquired ability of human-to-human transmission. While SARS-CoV-2 is relatively benign, it has infected more than half a million people (as of March 29th 2020) worldwide and the number of infected people continues to rise. More than 170 countries have reported COVID-19 positive cases. With a mortality rate of less than both the previous coronavirus outbreaks, COVID-19 has (conversely) caused the death of over 33,980 (as of 29th March, 2020 at 22.00 hours EDT) people worldwide and the number is increasing. Given the enormous impact of this virus on human health and wellbeing and consequent devastating impacts on world trade, economics and quality of life, it is important to understand this virus better and get insight into its pathogenic mechanisms which will aid in devising effective measure to curb its spread and predict future pattern of its interaction with humans. Though very little is known about this SARS-CoV-2 but its mechanisms and patterns of spread can be speculated (with caution, nevertheless) from what we know about its closest relatives SARS-CoV-1 (responsible for SARS-2002 epidemic) and MERS-CoV (responsible for MERS-2012 epidemic). In the present review, we aim at bringing together the coherent and peer reviewed literature about the SARS-CoV-2 and its close relatives and try to understand its infection patterns and reconstruct its pathogenic mechanisms with anecdotes on diagnosis and future directions. We hope that this paper will serve the purpose of being a reliable source of information to scientists, clinicians and general public.


  • Open Access

    Transcriptomic Analysis of the Neurogenesis Signature suggests Continued but Minimal Neurogenesis in the Adult Human Hippocampus

    by Ashutosh Kumar, Vikas Pareek, Muneeb A. Faiq, Pavan Kumar, Chiman Kumari, Himanshu N. Singh, Sanjib K. Ghosh

    Purpose: Since immunohistological investigations have given rise to divergent perspectives about continued hippocampal neurogenesis in adult humans, a comprehensive transcriptomic analysis of the neurogenesis signature markers supplemented with insights from gliogenesis and apoptotic markers (in context to the developmental stages across age) may discern important aspects and may well be the appropriate methodology for resolving this conflict. Materials and Methods: RNA expression data for the salient neurogenesis, gliogenesis, and apoptotic marker genes in post-mortem human hippocampal tissue of the Prenatal (n=15), Infant/Early childhood (n= 5), Adolescence (n=4), and Adulthood (n=6) ages were downloaded from Allen Brain Atlas database ( http://www.brainspan.org/rnaseq ). Gene expression data was categorized, median values were computed, and age group specific differential expression was statistically analyzed (the confidence level of 95%, p value ≤ 0.05 is used). Results: A sharp fall in prenatal to infant/early childhood expression was observed for all studied neurogenesis markers, except that for the post-mitotic late maturation (CALB1, CALB2, MAP2, NEUN, STMN2) which showed no significant differences in expression profiles. A continued post childhood decrease across advancing age was observed in the neural stem cells and progenitor markers with insignificant differences across close age groups. Uniquely, the postnatal sharp fall of KI67 and TBR2 continued across advancing age groups, reached near baseline until adolescent age. The immature granule cell, post mitotic early maturation, and late maturation markers showed a maintained or slightly increased (albeit insignificant) post childhood expression. The gliogenesis markers mostly showed a significant downregulation between prenatal and infant /early childhood age groups; this decline was persistent thereafter with insignificant differences between close age groups. A continued postnatal decrease occurred in apoptotic markers with observable, but insignificant, differences between adolescent and adult age. Conclusions: Our findings indicate a possibility of continued but minimal neurogenesis in the adult human hippocampus. A significant part of the newborn cells in the neurogenic niche may be glial cells. (Findings of this study were first presented at the Annual Meeting of Society for Neuroscience (SFN), 3 rd -7 th November, 2018, San Diego, USA. https://abstractsonline.com/pp8/#!/4649/presentation/37213 ) Graphical Highlights: A varying but continued fall in expression was observed for all studied neurogenesis markers across advancing age groups, except that for the immature granule cells, early and post-mitotic late neuronal maturation markers. A continued postnatal sharp fall of progenitor markers KI67 and TBR2 reached near baseline until adolescent age. Gliogenesis markers showed continued but insignificant fall in expression post infant/early childhood. Apoptotic markers showed continued post infant/early childhood downfall but changes were negligible between adolescent and adult age.


  • Open Access

    Non-Human Primates as Models for Diabetes Research: A Skeptic Outlook

    by Rizwana Qadri, Muneeb Faiq

    Apart from numerous parallels, human beings have different evolutionary, physiological and biochemical features when compared to non-human primates. This has particular relevance to our nutrition patterns, stress (and the relevant coping mechanisms) and energy metabolism. These differences make a case for Homo sapiens to be a distinct species with unusual categories of diseases for which non-human primates may not supplement as true model organisms. The comparatively larger human brain proportionate size and consequently higher energy demands, bipedal locomotion (ensuing immature brain development at birth), unique craniofacial and dental structures with increased quality, availability and bioavailability of food, distinct stress biochemistry and endocrinology with disparate adrenal and thyroid sizes to other primates predispose us to many disorders not found in other non-human primates. One of the most important of these syndromes is diabetes type-1. Since we know that autoimmune diabetes does not occur in non-human primates we may, at the outset, think that a true physiological and biochemical model of this disease in them may have important shortcomings. This paper discusses relevant physiological differences between Homo sapiens and other non-human primates lending enough support to the view that non-human primates may not substantiate as diabetes models for research. This paper puts forth imperative arguments centered upon differences between humans and other non-human primates in the light of brain size, body composition, evolutionary development, stress biochemistry, and energy metabolism. Finally, the discussion suggests that relevant factors should be taken into consideration when studying diabetes in these animal models. JMS 2018;21(1):61-67

  • Open Access

    Commentary: A Possible Mechanism of Zika Virus Associated Microcephaly: Imperative Role of Retinoic Acid Response Element (RARE) Consensus Sequence Repeats in the Viral Genome

    by Muneeb A. Faiq, Ashutosh Kumar, Himanshu N. Singh, Vikas Pareek, Pavan Kumar

    Commentary: A Possible Mechanism of Zika Virus Associated Microcephaly: Imperative Role of Retinoic Acid Response Element (RARE) Consensus Sequence Repeats in the Viral Genome